MASCOLO, Annamaria
 Distribuzione geografica
Continente #
EU - Europa 1.843
AS - Asia 1.481
NA - Nord America 1.076
SA - Sud America 325
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 4.753
Nazione #
US - Stati Uniti d'America 1.049
RU - Federazione Russa 877
SG - Singapore 501
CN - Cina 344
IE - Irlanda 337
BR - Brasile 274
IT - Italia 243
HK - Hong Kong 224
VN - Vietnam 145
GB - Regno Unito 98
DE - Germania 86
KR - Corea 78
IN - India 55
UA - Ucraina 55
JP - Giappone 46
GR - Grecia 27
TR - Turchia 27
AR - Argentina 23
FI - Finlandia 19
ID - Indonesia 17
EC - Ecuador 16
FR - Francia 14
CA - Canada 13
AT - Austria 12
BD - Bangladesh 11
MX - Messico 10
PL - Polonia 10
CZ - Repubblica Ceca 9
NL - Olanda 8
MA - Marocco 7
SC - Seychelles 7
SE - Svezia 7
BE - Belgio 6
ES - Italia 6
IQ - Iraq 6
ZA - Sudafrica 6
CL - Cile 4
DK - Danimarca 4
RS - Serbia 4
UZ - Uzbekistan 4
AL - Albania 3
CO - Colombia 3
LT - Lituania 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BY - Bielorussia 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KG - Kirghizistan 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
JO - Giordania 1
KH - Cambogia 1
KI - Kiribati 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PR - Porto Rico 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 4.753
Città #
Dublin 334
Moscow 289
Singapore 243
Hong Kong 224
Santa Clara 223
Chandler 108
Jacksonville 88
Seoul 78
Hefei 73
Dong Ket 60
Ashburn 57
Beijing 44
Bengaluru 42
Princeton 39
Roxbury 38
Naples 35
Bremen 34
Ho Chi Minh City 31
Hanoi 26
Medford 26
São Paulo 23
Aversa 21
New York 20
Los Angeles 19
Genoa 17
Milan 16
The Dalles 15
Cambridge 14
Ann Arbor 13
Dallas 13
Wilmington 12
Caserta 10
London 10
Rio de Janeiro 9
Boardman 8
Brno 8
Des Moines 8
Munich 8
Napoli 8
Rome 8
Woodbridge 8
Falkenstein 7
Jakarta 7
Nuremberg 7
Bologna 6
Brussels 6
Düsseldorf 6
Nanjing 6
Belo Horizonte 5
Hanover 5
Istanbul 5
Kunming 5
Redwood City 5
Toronto 5
Warsaw 5
Wroclaw 5
Arezzo 4
Atlanta 4
Auburn Hills 4
Baghdad 4
Biên Hòa 4
Brasília 4
Campinas 4
Guarulhos 4
Helsinki 4
Juelsminde 4
Lamezia Terme 4
Mexico City 4
Norwalk 4
Padova 4
Quito 4
Salerno 4
San Francisco 4
Tashkent 4
Acerra 3
Amsterdam 3
Athens 3
Caivano 3
Changsha 3
Chicago 3
Curitiba 3
Da Nang 3
Dhaka 3
Frankfurt am Main 3
Giugliano in Campania 3
Groningen 3
Guangzhou 3
Hải Dương 3
Johannesburg 3
Juiz de Fora 3
Lappeenranta 3
Newark 3
Paris 3
Pelotas 3
Pomigliano d'Arco 3
Porto Alegre 3
San Juan Bautista 3
Seattle 3
St Petersburg 3
Tirana 3
Totale 2.595
Nome #
Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation? 127
Campania preventability assessment committee (Italy): A focus on the preventability of non-steroidal anti-inflammatory drugs' adverse drug reactions 125
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review 123
Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugs 121
A case of figurate urticaria by etanercept 117
Improvement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of Italy 110
Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions 106
Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting system 103
Comparison of long-term clinical implications of beta-blockade in patients with obstructive airway diseases exposed to beta-blockers with different β1-adrenoreceptor selectivity: An Italian population-based cohort study 100
Dipeptidyl Peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: A Review of Clinical Cases 98
Effect of chronic kidney diseases on mortality among digoxin users treated for non-valvular atrial fibrillation: A nationwide register-based retrospective cohort study 95
Current and future therapeutic perspective in chronic heart failure 95
The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study 94
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 93
Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting( 91
Correction to: Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation? (Heart Failure Reviews, (2020), 10.1007/s10741-020-09961-9) 91
Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance 89
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study 88
The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19 80
Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias? 79
New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs) 79
Contribution of Italian clinical research for contrast media-induced nonrenal adverse drug reactions over the last three decades: A systematic review 78
COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database 77
Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System 76
The Early Access and the Potential Cost Savings by the Compassionate Use of Onco-haematological Drugs: Results from the Italian Study Compass-O 75
Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study 75
The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis 74
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study 73
Disease-Modifying Therapies (DMTs) in Pregnant and Lactating Women with Multiple Sclerosis: Analysis of Real-World Data from EudraVigilance Database 73
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials 72
Decolonization of drug-resistant Enterobacteriaceae carriers: A scoping review of the literature 72
New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): Focus on cardiovascular and neurological diseases 72
Renin-angiotensin system and coronavirus disease 2019: A narrative review 71
PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database 71
Thromboembolic Events after COVID-19 Vaccination: An Italian Retrospective Real-World Safety Study 71
Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database 70
Therapeutic strategies to fight COVID-19: Which is the status artis? 68
Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis 67
Pillars and Pitfalls of the New Pharmacovigilance legislation: Consequences for the identification of adverse drug reactions deriving from abuse, misuse, overdose, occupational exposure, and medication errors 67
Relationship between gender and the effectiveness of montelukast: An Italian/Danish register-based retrospective cohort study 67
Glucagon-like Peptide-1 Receptor Agonists and Suicidal Ideation: Analysis of Real-Word Data Collected in the European Pharmacovigilance Database 66
Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? 66
SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies 65
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database 64
Safety of dapagliflozin and empagliflozin in cases with diabetes mellitus or/and heart failure: a retrospective pharmacovigilance study conducted on the eudravigilance database 63
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: A Danish nationwide cohort study 63
Which is the top player for the cardiovascular safety? ibrutinib vs. obinutuzumab in CLL 61
Response to the comment “Is SGLT2i superior to DPP4i for primary and secondary prevention of cardiovascular diseases and death in patients with type 2 diabetes?” 61
Neutral endopeptidase (neprilysin) 60
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database 60
Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance 60
The efficacy and the safety of Eltrombopag in pediatric patients with Severe Aplastic Anemia: a systematic review 59
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase ® 59
Preventable cases of oral anticoagulant-induced bleeding: Data from the spontaneous reporting system 59
Endotoxin: Structure Source and Effects 58
Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System 58
Response to the comment on “SGLT-2 inhibitors reduce the risk of cerebrovascular/cardiovascular outcomes and mortality: A systematic review and meta-analysis of retrospective cohort studies” 58
Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: Nationwide cohort study 57
The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs. 57
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 56
Suspected adverse reactions to contrast media in Campania Region (Italy): Results from 14 years of post-marketing surveillance 56
Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article 55
The risk of fractures, acute myocardial infarction, atrial fibrillation and ventricular arrhythmia in geriatric patients exposed to promethazine 43
Retrospective Analysis of a Real-Life Use of Tixagevimab–Cilgavimab plus SARS-CoV-2 Antivirals for Treatment of COVID-19 38
Totale 4.875
Categoria #
all - tutte 20.119
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.119


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 8 22 15 5 7 30 63
2021/2022242 2 5 10 2 69 14 8 8 17 13 11 83
2022/2023620 74 28 15 34 53 40 4 26 297 7 25 17
2023/2024331 21 10 19 19 91 16 6 30 28 13 19 59
2024/20251.127 8 24 13 26 165 135 234 95 181 88 78 80
2025/20262.049 204 269 260 249 439 628 0 0 0 0 0 0
Totale 4.875